Drug Metabolism & Pharmacokinetics
Better predict pharmacokinetic (PK) and drug-drug interactions (DDIs) with DMPK/ADME studies and computational modeling on your compound, prior to clinical trials, to move quickly from discovery to development.
In Vivo Metabolism
- In Vivo Metabolism
- Fast PK | PK/TK Analysis & Reporting
- Radiolabeled ADME | hAME
- Bioequivalcence | Biosimilars
- Metabolite Identification (MetID)
- Human AME
- In Vitro / In Vivo Cross Species
- Metabolic Stability
- Radiolabeled ADME
Browse catalog capabilities
OPPTS 860.1300: Nature of the residue in plants, livestockResidue, Metabolism
Quantitative and/or systems pharmacology (QSP/SP) modelingMetabolism, Modeling, Pharmacology (Safety)
Enzyme identification (selective inhibitors & recombinant enzymes)Metabolism
In vivo pharmacokinetics (PK)Metabolism
Metabolic stability assaysMetabolism
Looking to get into the clinic quickly?
Consider the integration possibilities between your preclinical and clinical studies
For example, some PBPK pharmacometrics have been accepted in lieu of clinical DDI studies.